Rezultaty - Ronit Simantov
- Rezultaty 1 - 20 Rezultaty od 24
- Idź do następnej strony
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma od Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri
Wydane 2015Artigo -
9
Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice od Hayes M. Dansky, Sherri A. Charlton, John L. Sikes, Simon Heath, Ronit Simantov, Lawrence F. Levin, Pei Shu, Karen J. Moore, Jan L. Breslow, Jonathan D. Smith
Wydane 1999Artigo -
10
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors od Igor Puzanov, Colin R. Lindsay, Laura W. Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T.R. Jeffry Evans
Wydane 2014Artigo -
11
Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer od Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov
Wydane 2007Artigo -
12
Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer od April A. N. Rose, Andrée‐Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia MacDonald, Nicholas Bertos, Yves St‐Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M. Siegel
Wydane 2010Artigo -
13
Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors od Robin L. Jones, Edward S. Kim, Pilar Nava-Parada, Salma Alam, Faye M. Johnson, Andrew Stephens, Ronit Simantov, Srinivasu Poondru, Rich Gedrich, Scott M. Lippman, Stan B. Kaye, Craig P. Carden
Wydane 2014Artigo -
14
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus od Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis, Michael D. Lockshin, Lisa R. Sammaritano, Ronit Simantov, Mary K. Crow, Joseph E. Schwartz, Stephen A. Paget, Richard B. Devereux, Jane E. Salmon
Wydane 2003Artigo -
15
Statins and survival outcomes in patients with metastatic renal cell carcinoma od Rana R. McKay, Xun Lin, Laurence Albigès, André P. Fay, Marina D. Kaymakcalan, Suzanne S Mickey, P. Peter Ghoroghchian, Rupal S. Bhatt, Samuel Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Yick Chin Heng
Wydane 2015Artigo -
16
Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma od Patrick A. Ott, Omid Hamid, Anna C. Pavlick, Harriet M. Kluger, Kevin B. Kim, Peter D. Boasberg, Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, Thomas A. Davis, Mario Sznol, Patrick Hwu
Wydane 2014Artigo -
17
Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer od Johanna C. Bendell, Mansoor N. Saleh, April A. N. Rose, Peter M. Siegel, Lowell L. Hart, Surendra Sirpal, Suzanne F. Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas A. Davis, Linda T. Vahdat
Wydane 2014Artigo -
18
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis od Tim Eisen, T. Ahmad, Keith T. Flaherty, Martin Gore, Stan B. Kaye, Richard Marais, I. Gibbens, Samuel Hackett, Maggie James, Lynn M. Schuchter, Katherine L. Nathanson, Chenjing Xia, Ronit Simantov, Brian Schwartz, Melanie Poulin-Costello, Peter J. O’Dwyer, Mark J. Ratain
Wydane 2006Artigo -
19
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma od Aly‐Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé, John A. Steinharter, Dylan J. Martini, Ronit Simantov, Xun Lin, Xiao X. Wei, Bradley A. McGregor, Rana R. McKay, Lauren C. Harshman, Toni K. Choueiri
Wydane 2019Artigo -
20
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma od Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, M. Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski
Wydane 2007Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Oncology
Renal cell carcinoma
Gastroenterology
Biochemistry
Chemistry
Confidence interval
Hazard ratio
Immunology
Proportional hazards model
Biology
Hepatocellular carcinoma
Sorafenib
Adverse effect
Antibody
Cancer
Cancer research
Clinical trial
Pharmacology
Surgery
Pathology
Urology
Alternative medicine
Antibody-drug conjugate
Apoptosis
Cell biology
Clinical endpoint
Cohort
Discovery and development of mTOR inhibitors